Xyloxemine
- Level
- Commodity
- Parent
- 51162600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162650This classification denotes an antitussive agent with the molecular formula C23H33NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) L95KV83PV9, chemically known as 2-(2-(di-2,6-xylylmethoxy)ethoxy)-n,n-dimethylethylamine but more generally known as xyloxemine, which bears US NIH Compound Identifier 17800. European Medicines Agency schedules Xyloxemine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00123MIG. The term XYLOXEMINE is an International Non-Proprietary Name. XYLOXEMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule xyloxemine under HS 29221980 and SITC 51461. As of Q4 2014, XYLOXEMINE remains US FDA's Preferred Term for this commodity. Xyloxemine bears US NLM identifiers UMLS ID C1883581 and NCI Concept Code C66675. SMILES: O(C(C1C(CCCC1C)C)C1C(CCCC1C)C)CCOCCN(C)C.
Same parent
Under 51162600 · 55Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.